Quick-Muscle™ Skeletal – SeV Kit
Quick-Muscle™ Skeletal – SeV Kits enable the differentiation of human pluripotent stem cells into skeletal muscle cells using Sendai virus technology through an optimized and reproducible workflow.
Note: This kit is no longer available for individual sale. We now offer bulk orders and custom differentiation services to support your research and development needs.
Advantages of iPSC-Derived Skeletal Muscle
Skeletal Muscle Differentiation Kit Protocol
Explore our detailed differentiation protocols, a step-by-step guide designed to simplify and optimize your laboratory procedures using our iPSC-derived cells and differentiation kits. These protocols leverage the latest advancements in iPSC technology to ensure efficient and reproducible results.
Skeletal muscle morphology is confirmed via phase contrast imagery: Representative phase contrast images of Quick-Muscle™ Skeletal – mRNA Kit cell cultures on days 1-6 post-differentiation (scale bar = 100 μm)
Skeletal Muscle Characterization
Skeletal Muscle Marker Expression
iPSC-derived skeletal muscle cells express key markers and display typical morphology. Immunofluorescent staining of Quick-Muscle™ Skeletal cells shows typical skeletal muscle cell morphology and MHC expression. Immunofluorescent staining of Quick-Muscle™ Skeletal – mRNA cell cultures on day 6 post-differentiation show expression of myosin heavy chain (scale bar = 100 μm).
Product Specifications
| Parameters | Specifications |
|---|---|
| Product Name | Quick-Muscle™ Skeletal - SeV Kit |
| Catalog No. | SM-SeV |
| Product Components | QMS-SeV, Mesendoderm RNA, Component P, and Coating Material A |
| Storage Conditions | SeV should be stored at -80°C. All other components can be stored at -20°C or -80°C. |
| Cell Type | Skeletal Muscle |
| Induction Method | Transcription factors delivered by Sendai virus |
| Differentiation |
At day 7 post-differentiation (CW50065) >70% of cells express MHC positive cells |
| Sterility | No growth observed |
| Mycoplasma | No DNA detected |
| Restricted Use | For research use only. Not for use in diagnostic or therapeutic procedures. |
Excitatory Neuron Resources
Quick-Muscle™ Skeletal – SeV Kit
Characterization of iPSC-derived Skeletal Muscle Generated with Rapid Differentiation Method (Japan Muscle Society 2021)
Efficient differentiation of human pluripotent stem cells into skeletal muscle cells by combining RNA-based MYOD1-expression and POU5F1-silencing.
Epigenetic Manipulation Facilitates the Generation of Skeletal Muscle Cells from Pluripotent Stem Cells.
Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9.
Related Products
FAQs
Does Quick-Tissue™ technology leave a genetic footprint?
Sendai virus (SeV) is an RNA virus, so it does not integrate into the genomic DNA. In principle, a foreign gene introduced intracellularly in the form of RNA is quickly translated and expressed because, unlike DNA, RNA does not need to enter the nucleus for forced expression, thereby providing no chance of mutagenesis. This is discussed in the following review paper: Yamamoto, et al., (2009) “Current prospects for mRNA gene delivery.” Eur. J. Pharm Biopharm 71, 484-489.
Will SeV remain active after differentiation?
No. The SeV used in our kits is a temperature-sensitive mutant that is active at 33℃ but becomes inactive at 37℃, which is the temperature instructed in the user guides post-differentiation.
Is Sendai virus (SeV) dangerous?
SeV is not pathogenic to humans (i.e., humans are not the natural host of the virus) and the infection does not persist in immunocompetent animals. Furthermore, SeV used in our kits does not produce infectious viral particles upon transduction to host hPSCs and is a temperature-sensitive mutant, such that it is active at 33℃ but becomes inactive at 37℃. However, because SeV can be transmitted by aerosol and contact with respiratory secretions and is highly contagious, appropriate care must be taken to prevent potential mucosal exposure to the virus. Our SeV-based kits must be used under Biosafety Level 2 (BL-2) containment with a biological safety cabinet or a laminar flow hood and with appropriate personal protective equipment. In the event that the virus comes into contact with skin or eyes, decontaminate the affected area by flushing with plenty of water and follow the safety manual prepared by your laboratory and approved by your Institutional Biosafety Committee.
Do I need a license agreement for any of Ricoh Biosciences’ products?
No. You don’t need any licence or material transfer agreement (MTA) to use our differentiation kits or iPSC-derived cells. However, please be advised that these products are for research use only.
Contact Us
Have a question about our products, services, or custom projects? Our team is here to help—reach out and we’ll get back to you as soon as possible.
Subscribe
By signing up you are agreeing to our Privacy Policy




